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Subependymal giant-cell astrocytoma (SEGA) is a rare
intra-ventricular low-grade tumor which frequently occurs
as a manifestation of tuberous sclerosis complex. The
histogenesis of SEGA is controversial and its astrocytic
nature has been doubted. First studies suggested the astro-
cytic nature of SEGA while several recent reports demon-
strate its glio-neuronal nature. In spite of this, in the
recently revised WHO classification of the CNS tumors,
SEGA has been still included in the group of astrocytomas.
We studied nine tuberous sclerosis complex-associated
SEGAs. Patients were 1–18 years old. Eight patients (89%)
had a solitary lesion located in the lateral ventricle close to
of the head of the caudate nucleus, the remaining patient
(11%) had two tumors, one located close to the head of the
left caudate nucleus and the other in the central part of
the right lateral ventricle. Histologically, tumors were com-
posed of three types of cells: spindle, gemistocytic and
ganglion-like. Four tumors (44%) had a prominent vascu-
larization and three (33%) showed an angiocentric pattern.
Calcifications were observed in six cases (66%). By immu-
nohistochemistry, the majority of the tumors were GFAP-
(9; 100%), neurofilament- (8, 89%), neuron-specific
enolase- (9, 100%), and synaptophysin- (8; 89%) positive.
Ultrastructural studies were performed on four cases. In all
four there were glial cell processes filled with intermediate
filaments. In one case dense core putative neurosecretory
granules were appreciable. Our results emphasize the glio-
neuronal nature of SEGA. We suggest moving it into the
group of mixed glio-neuronal tumors under the denomina-
tion of subependymal giant cell tumor.
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INTRODUCTION
Subependymal giant-cell astrocytomas (SEGA) are rare
tumors associated with tuberous sclerosis complex. Tuber-
ous sclerosis complex is a neurocutaneous syndrome
which mainly involves the CNS where SEGAs, sub-
ependymal nodules, and cortical tubers may be present. In
the majority of cases, SEGAs arise in the first two decades
of life, from the head of the caudate nucleus near the
foramen of Monro and grow inside the lateral ventricle.
SEGAs are well circumscribed, often calcified, slowly
growing, and low grade (World Health Organization
[WHO] Grade I) tumors. Nevertheless, their outcome may
be poor due to obstructive hydrocephalus or due to intra-
tumoral hemorrhage.1
The histogenesis of SEGAs is controversial and their
pure astrocytic nature has been doubted. Initial studies
suggested the astrocytic character of SEGAs, while several
recent reports demonstrate their mixed, glio-neuronal,
nature.2–5 Indeed, SEGAs are formed by three main kinds
of cells, fibrillated spindle cells, swollen gemistocytic-like
cells and giant pyramidal cells with a ganglioid appearance,
which at the immunohistochemical and ultrastructural
level, show both glial and neuronal features. In spite of this,
in the recently revisedWHO classification of CNS tumors,1
SEGAs were still included in the group of astrocytic neo-
plasms. In this study we morphologically, immunohisto-
ichemically, and ultrastructurally studied a series of
Correspondence:Anna Maria Buccoliero, MD, PhD, Dipartimento di
Patologia Umana e Oncologia, Università degli Studi di Firenze Viale
G.B. Morgagni, 85, 50134 Firenze Italia. Email: ambuccoliero@unifi.it
Received 12 March 2008; revised 5 May 2008 and accepted 6 May
2008
Neuropathology 2009; 29, 25–30 doi:10.1111/j.1440-1789.2008.00934.x
© 2008 Japanese Society of Neuropathology
nine tuberous sclerosis complex-associated SEGAs. Our
purpose was to underline the mixed glio-neuronal nature
of this tumor.
PATIENTS AND METHODS
Nine tuberous sclerosis complex-associated SEGA speci-
mens were studied. They were obtained from nine con-
secutive patients surgically treated at the Neurosurgical
Service of the Anna Meyer Pediatric Hospital of Flo-
rence, Italy, between 2004 and 2007. There were four male
(44%) and five female (55%) patients. Ages ranged from
1 to 18 years at the time of the surgery (mean 6 years).
Eight patients (89%) had a solitary lesion located in the
lateral ventricle close to the head of the caudate nucleus,
the remaining patient (11%) had two tumors, one located
close to the head of the left caudate nucleus and the
other located in the medial part of the right lateral
ventricle. In all cases there were other CSN tuberous
sclerosis-associated lesions: subependymal nodules in
nine cases (100%) and cortical tubers in eight (89%). In
three patients (33%) tuberous sclerosis occurred in a
familial setting (father; father and grandmother; twins). In
two patients SEGA was prenatally diagnosed. The most
common symptom was seizures (7 cases; 78%). One
patient (11%) had acute raised intracranial pressure. One
patient (11%) was asymptomatic.
Histological, immunohistochemical, and ultrastructural
studies were undertaken in the Department of Human
Pathology and Oncology of the University of Florence.
Surgical specimens were routinely fixed in 10% buffered
neutral formalin and embedded in paraffin. Some 5-mm
sections were stained with HE for morphological evalua-
tion, and further 5-mm sections of the most representative
sample were mounted on electrostatic slides and used
for immunohistochemical studies. Immunohistochemical
studies (standard streptavidin-biotin technique) were per-
formed using the following primary antibodies: mono-
clonal antibody direct against GFAP (clone ZCG29),
prediluted (Zymed Laboratories, San Francisco, CA,
USA); neuron-specific enolase (NSE; clone MIG-N3, pre-
diluted, BioGenex, San Ramon, CA, USA); synaptophysin
(SP; clone Snp 88, prediluted, BioGenex) and multiclonal
antibody against neurofilaments (NF; pan-clone-low, inter-
mediate and high molecular weight subunits: DA2; FNP7;
RMb020.11, 1:20 dilution, Zymed). Microwave antigen
enhancement was utilized for all the used antibodies.
Immunohistochemical staining was performed on NEXES
automated immunostainer (Ventana Medical Systems,
Tucson, AZ, USA). Immunocoloration was evaluate sepa-
rately in each type of neoplastic cell (spindle, gemistocytic,
and ganglion-like cells) and was indicated as negative when
it was present in no more than 50% of the cells and as
positive if it was diffuse to more than 50% of the cells.
Furthermore, we graded the immunocoloration as +/- or +
on the basis of intensity of the staining (+/-: weak immu-
nocoloration; +: strong immunocoloration).
Ultrastructural studies were performed on four cases.
Tumor tissue fragments for electron microscopy were fixed
in 2.5% glutaraldehyde in 0.1 mol/L sodium cacodylate
buffer (pH 7.4) for 3 h, and post-fixed in 1% OsO4 in
0.1 mol/L veronal acetate buffer (pH 7.4) for 1 h.The tissue
samples were stained en bloc in 2% uranyl acetate in
50% ethanol, dehydrated in increasing concentrations of
ethanol, cleared in propylene oxide, embedded in epoxy
resin and cut using a diamond knife, with a Leica Ultracut
R microtome. Ultrathin serial sections were mounted on
formvar-coated Cu/Rh grids, stained with uranyl acetate
and lead citrate, and observed with a Philips 410 LS trans-
mission electron microscope.
RESULTS
Histologically, tumors were composed of three types of
cells: spindle cells, gemistocytic-like cells and occasional
ganglion-like cells (Fig. 1). A variable number of multi-
nucleated cells were also detected. Four tumors (44%) had
a prominent vascularization and three (33%) showed an
angiocentric architectural pattern (Fig. 2). Calcifications
were observed in six cases (66%).
By immunohistochemistry, the majority of the tumors
were GFAP- (9; 100%),NF- (8, 89%),NSE- (9, 100%), and
SP- (8; 89%) positive. In 5/9 GFAP-positive cases, spindle
cells and the intercellular reticular matrix immunostained
with anti-GFAP antibody (Fig. 3), while gemistocytic- and
ganglion-like cells were negative; in two cases both spindle
and gemistocytic cells were GFAP-positive; in the remain-
Fig. 1 Tumors were composed of three types of cells: spindle
cells, gemistocytic-like cells and ganglion-like cells. HE staining.
Original magnification ¥ 200.
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ing two GFAP-positive cases the immunostaining involved
spindle, gemistocytic, and ganglion-like cells (Fig. 4).
Antibody against NF stained only ganglion-like cells in six
cases (Fig. 5), while it stained either ganglion-like and
gemistocytic-like cells in two cases. NSE immunostaining
was appreciable in all three types of cells in all tumors but
one in which spindle cells were NSE-negative. SP immun-
ostaining was almost always weak, focal and detected in
gemistocytic- and ganglion-like cells in all eight SP-positive
tumors (Fig. 6) (Table 1).
Ultrastructurally, all cases presented a background of
glial cell processes filled with intermediate filaments, in
which a variable number of giant and multinucleated cells
were detected. The cytoplasm of these cells contained
several mitochondria, rough endoplasmic reticulum pro-
files, free ribosomes, multiple Golgi profiles, several
primary lysosomes and a well-developed cytoskeleton
composed mainly of microtubules and less prominent
bundles of intermediate filaments. In one case, we identi-
fied putative dense core neurosecretory granules in the
cytoplasm of multinucleated giant cells. Deposits of
calcium, which appeared as irregular electron-dense circu-
lar structures surrounding either amorphous matrix or cel-
lular debris, were detected in one case (Figs 7,8).
DISCUSSION
The histogenesis of SEGA is still unclear. A pathogenetic
link between subependymal nodules and SEGAs has
been suggested. Several studies have been demonstrated,
by sequential neuroimaging follow-up, that there is a
Fig. 2 Angiocentric architectural pattern.Original magnification
¥ 100.
Fig. 3 Immunohisochemistry: GFAP immunostaining at the
level of the spindle cells and of the intercellular reticular matrix.
Original magnification ¥ 200.
Fig. 4 Immunohisochemistry: diffuse GFAP immunostaining.
Original magnification ¥ 100.
Fig. 5 Immunohisochemistry: neurofilament immunostaining at
the level of ganglion-like cells. Original magnification ¥ 400.
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continuum from subependymal nodules to SEGAs. Nev-
ertheless, it is unclear if all or just a part of subependymal
nodules have this potential. Moreover, it is difficult to
distinguish either at the clinical or radiological level, the
nodules with evolutive property from those without this
property. Some authors have demonstrated that all sub-
ependymal nodules are clonal, have the capacity to pro-
liferate, and behave as true neoplasms.6–9
It has been recently noted that there are also morpho-
logical, immunohistochemical and molecular similarities
between SEGA and Type IIb focal cortical dysplasia.10,11
Type IIb focal cortical dysplasia is morphologically charac-
terized by the presence of large cells known as balloon cells.
In the opinion of some authors, Type IIb focal cortical
dysplasia could even be considered a focal form of tuberous
sclerosis.12 SEGA, cortical tubers, subependymal nodules,
and Type IIb focal cortical dysplasia could originate from
undifferentiated neuroepithelial cells which may remain
undifferentiated, or differentiate into astrocytic, neuronal,
Fig. 6 Immunohistochemistry: synaptophysin immunostaining
at the level of gemistocytic- and ganglion-like cells. Original mag-
nification ¥ 200.
Table 1 Immunohistochemical and ultrastructural results
Case Immunohistochemistry Ultrastructure
GFAP NF NSE SP
1 Spindle cells + - +/- - –
Gemistocytic-like cells + - +/- +/-
Ganglion-like cells - + +/- +/-
2 Spindle cells + - + - –
Gemistocytic-like cells + + + +/-
Ganglion-like cells + + + +
3 Spindle cells +/- - + - –
Gemistocytic-like cells - - + +/-
Ganglion-like cells - - + +/-
4 Spindle cells + - + - Large cells: microtubules, mitochondria, RER
profiles, free ribosomes, primary lysosomes.
Glial cell processes filled with intermediate
filaments
Gemistocytic-like cells - - + +/-
Ganglion-like cells - + + +
5 Spindle cells + - - - Large cells: microtubules, mitochondria, RER
profiles, multiple Golgi complexes, primary and
secondary lysosomes, calcium deposits around
amorphous matrix or cellular debris.
Glial cell processes filled with intermediate
filaments
Gemistocytic-like cells - - +/- +/-
Ganglion-like cells - + +/- +/-
6 Spindle cells + - + - –
Gemistocytic-like cells + + + +/-
Ganglion-like cells - + + +/-
7 Spindle cells + - +/- - Large cells: microtubules, mitochondria, RER
profiles, multiple Golgi complexes, primary
lysosomes, pynocytotic vescicles
Glial-cell processes filled with intermediate
filaments
Gemistocytic-like cells - - +/- +/-
Ganglion-like cells - + +/- +/-
8 Spindle cells + - + - Large cells: microtubules, intermediate filaments,
mitochondria, RER profiles, primary lysosomes,
dense core putative neurosecretory granules.
Glial cell processes filled with intermediate
filaments
Gemistocytic-like cells - - + +/-
Ganglion-like cells - + + +/-
9 Spindle cells + - +/- - –
Gemistocytic-like cells + - +/- -
Ganglion-like cells + + +/- -
NF, neurofilament; NSE, neuron-specific enolase; SP, synaptophysin; RER, rough endoplastic reticulum.
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or mixed glio-neuronal cells.7,13Analogously to SEGA, sub-
ependymal nodules and Type IIb focal cortical dysplasia
express immunohistochemically both glial and neuronal
markers.3,7,14–16 Among neuronal markers, SP expression is
generally reported as weak and focal in SEGAs.4,17
Subependymal giant-cell astrocytomas which we
studied were homogeneous enough at a morphological
level with only some differences concerning the architec-
ture of the lesion and the amount of calcifications. At the
immunohistochemical level, all studied cases revealed
mixed glio-neuronal features. Indeed, all lesions were both
neuronal- and glial marker-positive. However, there were
variations in the immunoprofile among the different cell
types and among the different tumors. At the ultrastruc-
tural level, SEGA giant cells which we studied had some
features suggestive of neuronal differentiation, including
the presence of microtubules, abundant rough endoplastic
reticulum cysternae and free ribosomes, while bundles of
intermediate filaments, indicative of glial differentiation,
were seen only in cytoplasmic processes which likely origi-
nated from spindle astrocytic cells in the background. In
addition, in one case we detected dense core granules that
we interpreted as putative neurosecretory granules. In
previous ultrastructural studies, other features strongly
supportive of neuronal differentiation were the presence
of a synapse between a tuber giant cell and an axonal
termination.18,19
Further studies on larger series are certainly necessary
to definitively understand the histogenesis of SEGA. Nev-
ertheless, in consideration of our results and of the previ-
ous scientific reports, we would suggest moving this entity
from the group of astrocytomas to the group of mixed
glio-neuronal tumors under the denomination of sub-
ependymal giant cell tumor.
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